| parent | Aztreonam | LP16041-3 |
| child | Aztreonam [Susceptibility] | 18868-0 |
| child | Aztreonam [Susceptibility] by Disk diffusion (KB) | 45-5 |
| child | Aztreonam [Susceptibility] by Gradient strip | 6982-3 |
| child | Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) | 44-8 |
| child | Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) | 43-0 |
| parent | Aztreonam | LP16041-3 |
| child | Aztreonam [Susceptibility] | 18868-0 |
| child | Aztreonam [Susceptibility] by Disk diffusion (KB) | 45-5 |
| child | Aztreonam [Susceptibility] by Gradient strip | 6982-3 |
| child | Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) | 44-8 |
| child | Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) | 43-0 |
| PartDisplayName | en-US | Aztreonam | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR